First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif., Aug ...

First fully integrated spatial multiomic assay from 10x Genomics (TXG) brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology PLEASANTON, Calif ...

Began global shipments of Xenium Analyzer, the highest throughput instrument for subcellular In Situ profiling PLEASANTON, Calif., Dec. 8, 2022 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), ...

PLEASANTON, Calif. - 10x Genomics, Inc. (NASDAQ:TXG), a life sciences technology company with a market capitalization of $1.7 billion and impressive gross margins of nearly 70%, announced Tuesday the ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology ...

米カリフォルニア州プレザントン本拠のDNA解析のスタートアップ「10x Genomics」が、スウェーデンのストックホルム本拠の「Spatial Transcriptomics」を買収し、遺伝子解析分野に新たなイノベーションをもたらそうとしている。買収金額は明かされていない。

The field of spatial transcriptomics utilizes technologies that map gene expression data to specific cellular locations within tissues. While traditional RNA sequencing methods generate quantitative ...

“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...